LNSR — LENSAR, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1320350 ·
Last close
$6.05
Market Cap
$73.23M
52W High
$12.23
52W Low
$5.06
ADV30
71,701
Next earnings
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 13,428,000 6,382,000 2,239,000 36,332,000 66,223,000 12,494,000 55,433,000
Dec 2025 16,025,000 6,937,000 -4,919,000 -1,458,000 71,430,000 12,974,000 97,449,000
Sep 2025 14,316,000 6,036,000 -7,580,000 -3,713,000 70,204,000 7,637,000 96,111,000
Jun 2025 13,935,000 7,024,000 -6,289,000 -1,764,000 70,414,000 7,150,000 93,466,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,831,000
Investing CF
$1,284,000
Financing CF
$10,258,000
CapEx
$-106,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-2.90
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-177,575,000
Inventory
$21,520,000
Receivables
$6,672,000
ST Investments
$5,004,000
EBIT TTM
$-24,578,000
Pretax Income TTM
$-34,280,000
Interest Exp TTM
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$57,704,000
EBITDA
$-11,842,000
Free Cash Flow
$-17,200,624
Enterprise Value
$76,578,360
Total Cash
$13,495,000
Total Debt
$2,574,000
Shares Out
12,104,328
Trailing EPS
$-0.55
Book Value
$0.89
ROE
362.5%
ROA
-14.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 58,435,000 -24,578,000 -34,280,000 71,430,000 97,449,000 -14,831,000
Dec 2024 53,494,000 -6,936,000 -31,404,000 66,297,000 61,435,000 -2,275,000
Dec 2023 42,164,000 -12,229,000 -14,383,000 69,585,000 36,156,000 -9,659,000
Dec 2022 35,358,000 -20,177,000 -19,914,000 55,844,000 13,860,000 -14,856,000

TTM Snapshot

Revenues TTM
$12,636,000
NetIncome TTM
$-9,043,000
OpCashFlow TTM
$0
Assets (Latest)
$66,297,000
Forward EPS
$-0.71

Peers — same industry

TickerNameMarket CapLastDaily %
ECOR electroCore, Inc. $73.91M $8.91
AGPU Axe Compute Inc. $72.00M $6.92
RTGN RetinalGenix Technologies Inc. $75.02M $4.00
MDAI Spectral AI, Inc. $75.42M $2.37
STSS Sharps Technology Inc. $77.03M $1.82

News headlines (Yahoo Finance, 1h cache)

LENSAR Q1 Earnings Call Highlights
2026-05-08 18:20 · Yahoo
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
2026-05-08 11:00 · Yahoo
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
2026-04-30 11:00 · Yahoo
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
2026-04-21 05:03 · Yahoo
Cedar Grove Capital Management’s Views on LENSAR (LNSR)
2026-04-20 13:00 · Yahoo
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
2026-04-05 00:18 · Yahoo
LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
2026-04-04 01:00 · Yahoo
LENSAR, Inc. Q4 2025 Earnings Call Summary
2026-04-01 12:30 · Yahoo
LENSAR Q4 Earnings Call Highlights
2026-03-31 14:10 · Yahoo
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
2026-03-31 10:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.